Skip to content

Study on Effect of Liuzijue Qigong on Postoperative Rehabilitation of Patients with Non-small Cell Lung Cancer Patients after Thoracoscopic Lobectomy Based on Enhanced Recovery after Surgery

Study on Effect of Liuzijue Qigong on Postoperative Rehabilitation of Patients with Non-small Cell Lung Cancer Patients after Thoracoscopic Lobectomy Based on Enhanced Recovery after Surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069696
Enrollment
Unknown
Registered
2023-03-23
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

control group:Routine preoperative preparation, including smoking ban, deep breathing, etc
intervention group 1:Routine preoperative preparation, including smoking ban, deep breathing, etc+Respiratory trainer
intervention group 2:Routine preoperative preparation, including smoking ban, deep breathing, etc+Respiratory trainer+liuzijue

Sponsors

The Second Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1)meet the diagnostic criteria for non-small cell lung cancer; (2) be between the ages of 18 and 65; (3)Non-small cell lung cancer with tumor stage I–II, T1-3N0M0, T1-2N1M0 non-small cell lung cancer, proposed to undergo thoracoscopic lobectomy without adjuvant treatment such as chemotherapy after the surgery; (4) Normal language communication, the ability to comprehend the pertinent contents of the scale and complete the evaluator; (5)patients with normal cognitive function and limb movement function who can practice the liuzijue (6) informed consent and voluntary participation, and the willingness to sign informed consent are all required.

Exclusion criteria

Exclusion criteria: Exclusion criteria: (1) combined with patients with other severe mental illness; (2) combined with severe primary diseases such as liver, kidney and hematopoietic system;

Design outcomes

Primary

MeasureTime frame
peak expiratory flow;blood gas index;complication;recovery room observation time;early recovery of quality;

Countries

China

Contacts

Public Contactsuxuee

The Second Affiliated Hospital of Fujian Medical University

479847293@qq.com18905061326

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026